HomeCompareMHGVY vs PFE

MHGVY vs PFE: Dividend Comparison 2026

MHGVY yields 2.35% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MHGVY wins by $130.72M in total portfolio value
10 years
MHGVY
MHGVY
● Live price
2.35%
Share price
$22.97
Annual div
$0.54
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$130.77M
Annual income
$120,883,740.18
Full MHGVY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — MHGVY vs PFE

📍 MHGVY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMHGVYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MHGVY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MHGVY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MHGVY
Annual income on $10K today (after 15% tax)
$199.67/yr
After 10yr DRIP, annual income (after tax)
$102,751,179.15/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, MHGVY beats the other by $102,728,859.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MHGVY + PFE for your $10,000?

MHGVY: 50%PFE: 50%
100% PFE50/50100% MHGVY
Portfolio after 10yr
$65.41M
Annual income
$60,454,999.45/yr
Blended yield
92.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MHGVY
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
2.3
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MHGVY buys
0
PFE buys
0
No recent congressional trades found for MHGVY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMHGVYPFE
Forward yield2.35%6.13%
Annual dividend / share$0.54$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$130.77M$49.6K
Annual income after 10y$120,883,740.18$26,258.71
Total dividends collected$130.00M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: MHGVY vs PFE ($10,000, DRIP)

YearMHGVY PortfolioMHGVY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,170$469.82$9,153$693.39+$2.0KMHGVY
2$12,933$980.90$8,593$849.25+$4.3KMHGVY
3$15,961$2,122.81$8,336$1,066.78+$7.6KMHGVY
4$21,975$4,896.93$8,437$1,384.80+$13.5KMHGVY
5$36,115$12,602.14$9,013$1,875.40+$27.1KMHGVY
6$77,356$38,712.82$10,306$2,680.72+$67.0KMHGVY
7$237,762$154,990.48$12,820$4,101.38+$224.9KMHGVY
8$1,144,831$890,426.47$17,673$6,826.70+$1.13MMHGVY
9$9,238,874$8,013,904.24$27,543$12,591.86+$9.21MMHGVY
10$130,769,335$120,883,740.18$49,560$26,258.71+$130.72MMHGVY

MHGVY vs PFE: Complete Analysis 2026

MHGVYStock

Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. The company operates through three segments: Feed, Farming, and Sales and Marketing. It is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. The company offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. It also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. The company offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.

Full MHGVY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MHGVY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MHGVY vs SCHDMHGVY vs JEPIMHGVY vs OMHGVY vs KOMHGVY vs MAINMHGVY vs JNJMHGVY vs MRKMHGVY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.